# E02 final model choice: retain initial

Reviewed the actual combined feedback for `e02_initial_8100` at `biomedical_research/virtual_cohort_system/work/core_workflow_replication_2026-11-04/sessions/E02/feedback_e02_initial_8100.json`. Its SHA-256 was independently read and matched **2ba0ea96d4eb0a3186aca5b7de97987f59d06adaaebbc9fb39afe71d52344b48**. The report binds frozen initial candidate **10be6ae5aba5c2f9988fd03d96dfb585479bfe3cb801ae08949a848635db88b8**, verified output linkage and a recorded generator execution. It explicitly reports `reference_read: false` and does not assess scientific validity.

No candidate or existing source/root artifact was modified. No extra search, local generator import/execution, new rows or final-delivery inspection occurred. This decision is made before the fixed final deliveries.

## Execution and model behavior

The charged isolated trial succeeded with 3,000 rows, all eight cells containing exactly 375, no duplicate measurement rows, and completed Q1/Q2/Q3 and all provider-defined diagnostics. I reviewed the supplied marginal means, population SDs and 10th/50th/90th percentiles, demographic quality checks, regression ranks and residual diagnostic. No uncomputable requested analysis or numerical failure was reported. Successful ordinary draws do not eliminate the sampler's explicit extreme-representability failure conditions.

The constructed conditional-mean implications were Q1 0.100 per decade and Q3 0.050 per five BMI units; the single realized trial returned 0.101172 and 0.052592. Q2 was 0.073897 and the Q2–Q3 difference 0.021306. Residual RMS was 0.327370, compared with the specified conditional individual SD 0.325217. These observations show behavior compatible with the submitted law; they are not new estimates from real participants, significance tests, or independent validation. No seed was selected to make these values closer to their model implications.

## All available source comparisons

The seven approximate checks used 2,981 generated rows after the declared source-like HbA1c/age/glucose filters. They retain missing source risk/medical/treatment exclusions, differing design and assay/serum-plasma assumptions.

| Source statistic | Reported | Trial comparison | Raw difference |
|---|---:|---:|---:|
| Age mean, years | 47.8 | 53.846025 | +6.046025 |
| Age sample SD, years | 14.6 | 16.562069 | +1.962069 |
| Glucose mean, mg/dL | 93.0 | 93.913423 | +0.913423 |
| Glucose sample SD, mg/dL | 11.0 | 11.009858 | +0.009858 |
| HbA1c mean, % | 5.4 | 5.460341 | +0.060341 |
| HbA1c sample SD, percentage points | 0.4 | 0.401750 | +0.001750 |
| Unadjusted HbA1c-on-glucose slope, %/(mg/dL) | 0.0158 | 0.01602157 | +0.00022157 |

The age difference is principally structural: the task requires an equal-cell age design, whereas the Italian source has a different age distribution. It is not evidence to change the prescribed design. The older design propagates into glucose and HbA1c means under the declared positive age terms, so forcing those means back to the source values would change the model for a population-mismatch reason. The small scale/slope differences are not assigned a significance interpretation: source summary rounding, selected versus untruncated surrogate calibration, transport/model assumptions and Monte Carlo variation are distinct and not numerically separated by this one trial. No estimator uncertainty was manufactured from source SD or sample size.

All eight unavailable checks remain unavailable: NHANES adjusted age and BMI mean (survey weighting); Huang male coefficient (sex recoding); SHIP BMI quartiles (unreported interpolation); Italian reported correlation (unreported estimator and incompatible summaries); equation intercept (unsupported operator and intentionally unfitted constraint); and HGI-group context (unsupported rich grouping/unknown within-group relationships). None was replaced by a convenient alternative statistic.

## Reason for no revision

The feedback identifies no new extraction, contract, arithmetic or implementation defect. It also does not identify the unreported target joint law or resolve the main transport assumptions. Reducing these source discrepancies alone would not establish a more appropriate cohort for the task and could erase the intended age design or overfit one realization. I therefore retain `candidates/initial` unchanged, with no scientific revision or additional trial requested.

Q2/Q3 remain substantially assumption-dependent, and the source-based age coefficient still requires population/measurement transport. Valid rows and source consistency do not support national prevalence estimation, diagnosis, causal inference, individual prediction or a claim of target-population recovery. The bound final decision is in `FINAL_DECISION.json`.
